3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
2
Solid Tumors
1
Myelodysplastic Syndromes
1
Leukemia, Myelomonocytic, Chronic
1
Interventions
Azacitidine
23
fludarabine phosphate
17
Cyclophosphamide
16
Decitabine
12
Cytarabine
11
Peripheral Blood Stem Cell Transplantation
10
Whole-Body Irradiation
9
Mycophenolic Acid
9
Filgrastim
8
Tacrolimus
7
Cyclosporine
7
venetoclax
6
decitabine and cedazuridine drug combination
6
fludarabine
5
Carboplatin
5
sargramostim
4
Vorinostat
4
Specimen Handling
4
Sirolimus
4
Radiotherapy
4
Injections
4
Cyclosporins
4
Clofarabine
4
Busulfan
4
ruxolitinib
3
cedazuridine
3
aldesleukin
3
Topotecan
3
Melphalan
3
Leucovorin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Leukemia, Myelomonocytic, Chronic
×
glasdegib
×
Clear all
NCT02367456
2024-01-19
BRIGHT 1012
Pfizer
Phase 1
Completed
73 enrolled
31 charts